MNKD vs. RXRX

Last updated Aug 1, 2026

MNKD (MannKind Corporation) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, MNKD returned -0.94%/yr vs -37.05%/yr for RXRX. Their 0.39 correlation means their historical movements had little consistent relationship.

Performance

MNKD vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MannKind Corporation (MNKD) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MNKD achieves a -31.04% return, which is significantly lower than RXRX's -26.65% return.

MNKD

• 1D: -4.87%
• 1M: -13.50%
• 6M: -32.35%
• YTD: -31.04%
• 1Y: 4.27%
• 3Y*: -4.51%
• 5Y*: -0.94%
• 10Y*: -2.33%
• ALL TIME*: -12.69%

RXRX

• 1D: -1.32%
• 1M: -21.05%
• 6M: -28.40%
• YTD: -26.65%
• 1Y: -47.18%
• 3Y*: -39.89%
• 5Y*: -37.05%
• 10Y*: —
• ALL TIME*: -35.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
MNKD MannKind Corporation	$18.89M	$19.49M	$21.96M
RXRX Recursion Pharmaceuticals, Inc.	$52.74M	$74.51M	$69.08M

MNKD vs. RXRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
MNKD MannKind Corporation	-31.04%	-11.82%	76.65%	-30.93%	20.59%	1.63%
RXRX Recursion Pharmaceuticals, Inc.	-26.65%	-39.50%	-31.44%	27.89%	-54.99%	-42.90%

Correlation

The correlation between MNKD and RXRX is 0.28, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.28
Correlation (3Y) Balances recent behavior with more history.	0.35
Correlation (5Y) Shows whether the relationship held over a longer period.	0.40
Correlation (All Time) Calculated using the full available price history since Apr 16, 2021	0.39

The correlation between MNKD and RXRX shifts across timeframes, from 0.28 (1 year) to 0.40 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap MNKD : $1.21B RXRX : $1.57B
EPS MNKD : -$0.08 RXRX : -$1.12
PS Ratio MNKD : 3.37 RXRX : 22.67
Total Revenue (TTM) MNKD : $360.78M RXRX : $66.29M
Gross Profit (TTM) MNKD : $285.93M RXRX : -$22.83M
EBITDA (TTM) MNKD : $23.43M RXRX : -$505.90M

Return for Risk

MNKD vs. RXRX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MNKD

MNKD Risk / Return Rank: 48
MNKD Sharpe Ratio Rank: 47
MNKD Sortino Ratio Rank: 49
MNKD Omega Ratio Rank: 53
MNKD Calmar Ratio Rank: 46
MNKD Martin Ratio Rank: 46

RXRX

RXRX Risk / Return Rank: 13
RXRX Sharpe Ratio Rank: 12
RXRX Sortino Ratio Rank: 13
RXRX Omega Ratio Rank: 16
RXRX Calmar Ratio Rank: 10
RXRX Martin Ratio Rank: 14

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MNKD vs. RXRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MannKind Corporation (MNKD) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MNKD	RXRX	Difference
Sharpe ratio: Return per unit of total volatility	0.05	-0.71	+0.76
Sortino ratio: Return per unit of downside risk	0.62	-0.96	+1.58
Omega ratio: Gain probability vs. loss probability	1.09	0.90	+0.19
Calmar ratio: Return relative to maximum drawdown	0.05	-0.85	+0.91
Martin ratio: Return relative to average drawdown	0.11	-1.25	+1.35

MNKD vs. RXRX - Sharpe Ratio Comparison

The current MNKD Sharpe Ratio is 0.05, which is higher than the RXRX Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of MNKD and RXRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

MNKD vs. RXRX - Drawdown Comparison

The maximum MNKD drawdown since its inception was -99.41%, which is greater than RXRX's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for MNKD and RXRX.

Drawdown Indicators

	MNKD	RXRX	Difference
Max Drawdown Largest peak-to-trough decline	-99.41%	-93.13%	-6.28%
Max Drawdown (1Y) Largest decline over 1 year	-63.29%	-58.17%	-5.12%
Max Drawdown (3Y) Largest decline over 3 years	-69.35%	-81.70%	+12.35%
Max Drawdown (5Y) Largest decline over 5 years	-69.35%	-90.95%	+21.60%
Max Drawdown (10Y) Largest decline over 10 years	-87.48%	—	—
Current Drawdown Current decline from peak	-96.70%	-92.74%	-3.96%
Average Drawdown Average peak-to-trough decline	-81.20%	-75.79%	-5.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	32.18%	39.99%	-7.81%

Volatility

MNKD vs. RXRX - Volatility Comparison

MannKind Corporation (MNKD) has a higher volatility of 19.74% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 17.39%. This indicates that MNKD's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MNKD	RXRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.74%	17.39%	+2.35%
Volatility (6M) Calculated over the trailing 6-month period	64.93%	45.40%	+19.53%
Volatility (1Y) Calculated over the trailing 1-year period	74.24%	69.61%	+4.63%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.40%	93.18%	-33.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	83.40%	92.91%	-9.51%

Dividends

MNKD vs. RXRX - Dividend Comparison

Neither MNKD nor RXRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both MNKD and RXRX in my portfolio?

MNKD and RXRX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MNKD or RXRX?

MNKD has higher volatility (19.74%) compared to RXRX (17.39%). In terms of maximum drawdown, MNKD dropped -99.41% vs RXRX's -93.13%.

Which has better risk-adjusted returns?

MNKD currently has the higher Sharpe Ratio (0.05 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.